186 Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) – a case series
Fraser, I.M., Brooke, A.M., Dorey, N.E., Toy, E.W.Volume:
83
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(14)70187-4
Date:
January, 2014
File:
PDF, 61 KB
english, 2014